Grosios, K <br/><br/>
Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis.  [electronic resource] 

 -  Inflammation research : official journal of the European Histamine Research Society ... [et al.]  Apr 2004 
 - 133-42 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1023-3830 
<br/><br/><label>Standard No.: </label>10.1007/s00011-003-1230-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Arthritis, Rheumatoid--drug therapy<br/>Collagen--immunology<br/>Female<br/>Hyperalgesia--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred DBA<br/>Phthalazines--pharmacology<br/>Pyridines--pharmacology<br/>Rats<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors